Arm Skeletal Muscle Mass Is Associated With the Prognosis of Patients With Cirrhosis

被引:6
|
作者
Shimono, Yoshihiro [1 ]
Enomoto, Hirayuki [1 ]
Kishino, Kyohei [1 ]
Moriwaki, Ei-Ichiro [1 ,2 ]
Nishikawa, Hiroki [1 ]
Nishimura, Takashi [1 ]
Iwata, Yoshinori [1 ]
Iijima, Hiroko [1 ]
Nishiguchi, Shuhei [1 ]
机构
[1] Hyogo Coll Med, Dept Internal Med, Div Hepatobiliary & Pancreat Dis, Mukogawa Chol 1, Nishinomiya, Hyogo 6638501, Japan
[2] Kano Gen Hosp, Dept Gastroenterol, Osaka, Japan
来源
IN VIVO | 2020年 / 34卷 / 03期
关键词
Bioimpedance analysis; skeletal muscle mass index; upper limbs; liver cirrhosis; prognosis; WORKING GROUP; SARCOPENIA; BIOIMPEDANCE; CONSENSUS;
D O I
10.21873/invivo.11889
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background/Aim: This study aimed to assess the clinical significance of measuring the arm skeletal muscle mass in patients with cirrhosis. Patients and Methods: Using body composition data measured with the bioimpedance analysis (BIA) method, the skeletal muscle mass index (SMI) values of the arm (arm skeletal muscle mass/height(2)) and leg (leg skeletal mass muscle/height(2)) were calculated for 353 patients with cirrhosis, and the relationships of these indices to their prognosis were assessed. In addition, overhydration of the upper and lower limbs was compared. Results: Arm SMI was significantly positively associated with the prognosis of patients with cirrhosis (p=0.0002) but leg SMI was not (p=0.0829). The rate of overhydration in the lower limbs was significantly higher than that in the upper limbs (p<0.0001). Conclusion: Arm SMI measured with the BIA method was suggested to be minimally affected by water retention, and might be clinically useful for patients with cirrhosis.
引用
收藏
页码:1165 / 1171
页数:7
相关论文
共 50 条
  • [1] The loss of skeletal muscle mass is associated with poor prognosis in the patients with chronic liver disease
    Ebinuma, Hirotoshi
    Saito, Hidetsugu
    Wakayama, Yuko
    Yamaguchi, Akihiro
    Miyake, Rei
    Shiba, Shunsuke
    Taniki, Nobuhito
    Usui, Shingo
    Chu, Po-sung
    Nakamoto, Nobuhiro
    Sugiyama, Kazuo
    Kanai, Takanori
    [J]. HEPATOLOGY, 2015, 62 : 492A - 492A
  • [2] Risk factors for loss of skeletal muscle mass in patients with cirrhosis
    Sung, Ji Hyun
    Uojima, Haruki
    Hidaka, Hisashi
    Tanaka, Yoshiaki
    Wada, Naohisa
    Kubota, Kousuke
    Nakazawa, Takahide
    Shibuya, Akitaka
    Fujikawa, Tomoaki
    Yamanoue, Hiroki
    Kako, Makoto
    Koizumi, Wasaburo
    [J]. HEPATOLOGY RESEARCH, 2019, 49 (05) : 550 - 558
  • [3] The creatinine approach to estimate skeletal muscle mass in patients with cirrhosis
    Pirlich, M
    Selberg, O
    Boker, K
    Schwarze, M
    Muller, MJ
    [J]. HEPATOLOGY, 1996, 24 (06) : 1422 - 1427
  • [4] Skeletal muscle mass predicts the prognosis of patients with intrahepatic cholangiocarcinoma
    Yugawa, Kyohei
    Itoh, Shinji
    Kurihara, Takeshi
    Yoshiya, Shohei
    Mano, Yohei
    Takeishi, Kazuki
    Harada, Noboru
    Ikegami, Toru
    Soejima, Yuji
    Mori, Masaki
    Yoshizumi, Tomoharu
    [J]. AMERICAN JOURNAL OF SURGERY, 2019, 218 (05): : 952 - 958
  • [5] Measurement of skeletal muscle volume is useful for predicting prognosis in patients with liver cirrhosis
    Matsui, Teppei
    Nagai, Hidenari
    Watanabe, Gou
    Mouri, Kunihide
    Yoshimine, Naoyuki
    Amanuma, Makoto
    Kobayashi, Kojirou
    Ogino, Yu
    Mukozu, Takanori
    Matsukiyo, Yasushi
    Daidou, Yasuko
    Wakui, Noritaka
    Nakano, Shigeru
    Momiyama, Koichi
    Matsuda, Takahisa
    Igarashi, Yoshinori
    [J]. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2022, 34 (11) : 1151 - 1157
  • [6] LOW SKELETAL MUSCLE MASS IS ASSOCIATED WITH INCREASED HOSPITAL COSTS IN PATIENTS WITH CIRRHOSIS LISTED FOR LIVER TRANSPLANTATION
    Van Vugt, Jeroen
    Buettner, Stefan
    Alferink, Louise
    Bossche, Niek
    De Bruin, Ron
    Murad, Sarwa Darwish
    Polak, Wojciech
    Metselaar, Herold
    Ijzermans, Jan
    [J]. TRANSPLANT INTERNATIONAL, 2017, 30 : 72 - 72
  • [7] Treatment of Splenomegaly Associated with Cirrhosis of the Liver Will Lead to Improvement in Skeletal Muscle Mass
    Koizumi, Yohei
    Hirooka, Masashi
    Miyake, Teruki
    Tanaka, Takaaki
    Yukimotol, Atsushi
    Imai, Yuusuke
    Nakamura, Yoshiko
    Watanabe, Takao
    Yoshida, Osamu
    Kumagi, Teru
    Abe, Masanori
    Hiasa, Yoichi
    [J]. HEPATOLOGY, 2018, 68 : 1166A - 1166A
  • [8] Skeletal Muscle and Lean Body Mass Loss Are Associated with Poorer Prognosis in Patients with NSCLC Treated with Afatinib
    De La Torre-Vallejo, Martha
    Turcott, Jenny
    Luvian, Julissa
    Arrieta Rodriguez, Oscar
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S230 - S230
  • [9] IMPACT OF SKELETAL MUSCLE MASS ON PROGNOSIS IN PATIENTS WITH ACUTE CORONARY SYNDROME
    Mizuguchi, Yukio
    Yamada, Takeshi
    Taniguchi, Norimsa
    Nakajima, Shunsuke
    Hata, Tetsuya
    Takahashi, Akihiko
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2020, 75 (11) : 3510 - 3510
  • [10] Third lumbar skeletal muscle mass index and patients with liver cirrhosis and ascites
    Chen, Yongxin
    Li, Xiaofei
    [J]. CLINICAL NUTRITION, 2020, 39 (12) : 3846 - 3846